Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Gomez

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Pain|June 23, 2020
Studies on CRMP2 SUMOylation-deficient transgenic mice identify sex-specific Nav1.7 regulation in the pathogenesis of chronic neuropathic painAubin Moutal, Song Cai, Jie Yu, et al.
ACS Chemical Neuroscience|June 7, 2022
Stereospecific Effects of Benzimidazolonepiperidine Compounds on T-Type Ca<sup>2+</sup> Channels and PainKimberly Gomez, Cheng Tang, Bin Tan, et al.
The Journal of Clinical Investigation|November 26, 2024
Neuropilin-1 inhibition suppresses nerve growth factor signaling and nociception in pain modelsChloe J Peach, Raquel Tonello, Elisa Damo, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Neuropilin-1 is a co-receptor for Nerve Growth Factor-evoked painChloe J Peach, Raquel Tonello, Elisa Damo, et al.
Pain|June 17, 2020
A modulator of the low-voltage-activated T-type calcium channel that reverses HIV glycoprotein 120-, paclitaxel-, and spinal nerve ligation-induced peripheral neuropathiesSong Cai, Peter Tuohy, Chunlong Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2023
Identification and targeting of a unique Na<sub>V</sub>1.7 domain driving chronic painKimberly Gomez, Harrison J Stratton, Paz Duran, et al.
Anesthesiology|June 9, 2026
Dual Roles of Voltage-gated Calcium Channels and γ-Aminobutyric Acid-mediated Signaling in Modulating Neurotensin Receptor Type 2-induced AntinociceptionLaurent François Martin, Kimberly Gomez, Joon Park, et al.
ACS Pharmacology & Translational Science|November 20, 2025
Quinoline-Based Neuropilin‑1 Antagonists Exhibit a Pure Antagonist Profile and Block Vascular Endothelial Growth Factor-Induced PainSara Hestehave, Silvia Dragoni, Philip Fallon, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Mechanism, and treatment of anti-CV2/CRMP5 autoimmune painLaurent Martin, Harrison J Stratton, Kimberly Gomez, et al.
Nature Communications|August 7, 2025
Anti-CV2/CRMP5 autoantibodies as drivers of sensory neuron excitability and pain in ratsLaurent Martin, Harrison J Stratton, Lyuba Y Salih, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Pain|June 23, 2020
Studies on CRMP2 SUMOylation-deficient transgenic mice identify sex-specific Nav1.7 regulation in the pathogenesis of chronic neuropathic painAubin Moutal, Song Cai, Jie Yu, et al.
ACS Chemical Neuroscience|June 7, 2022
Stereospecific Effects of Benzimidazolonepiperidine Compounds on T-Type Ca<sup>2+</sup> Channels and PainKimberly Gomez, Cheng Tang, Bin Tan, et al.
The Journal of Clinical Investigation|November 26, 2024
Neuropilin-1 inhibition suppresses nerve growth factor signaling and nociception in pain modelsChloe J Peach, Raquel Tonello, Elisa Damo, et al.
Biorxiv : the Preprint Server for Biology|December 18, 2023
Neuropilin-1 is a co-receptor for Nerve Growth Factor-evoked painChloe J Peach, Raquel Tonello, Elisa Damo, et al.
Pain|June 17, 2020
A modulator of the low-voltage-activated T-type calcium channel that reverses HIV glycoprotein 120-, paclitaxel-, and spinal nerve ligation-induced peripheral neuropathiesSong Cai, Peter Tuohy, Chunlong Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2023
Identification and targeting of a unique Na<sub>V</sub>1.7 domain driving chronic painKimberly Gomez, Harrison J Stratton, Paz Duran, et al.
Anesthesiology|June 9, 2026
Dual Roles of Voltage-gated Calcium Channels and γ-Aminobutyric Acid-mediated Signaling in Modulating Neurotensin Receptor Type 2-induced AntinociceptionLaurent François Martin, Kimberly Gomez, Joon Park, et al.
ACS Pharmacology & Translational Science|November 20, 2025
Quinoline-Based Neuropilin‑1 Antagonists Exhibit a Pure Antagonist Profile and Block Vascular Endothelial Growth Factor-Induced PainSara Hestehave, Silvia Dragoni, Philip Fallon, et al.
Biorxiv : the Preprint Server for Biology|May 20, 2024
Mechanism, and treatment of anti-CV2/CRMP5 autoimmune painLaurent Martin, Harrison J Stratton, Kimberly Gomez, et al.
Nature Communications|August 7, 2025
Anti-CV2/CRMP5 autoantibodies as drivers of sensory neuron excitability and pain in ratsLaurent Martin, Harrison J Stratton, Lyuba Y Salih, et al.
Pageof 5